These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2121848)

  • 21. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
    Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
    APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
    El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F
    Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
    Nessim NG; Demerdash Z
    Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of simultaneous and/or consecutive administration of the broad spectrum anthelmintic flubendazole together with praziquantel in experimental Schistosoma mansoni infection.
    William S; Guirguis F; Nessim NG
    Arzneimittelforschung; 2003; 53(7):532-7. PubMed ID: 12918221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety.
    Navaratnam AM; Sousa-Figueiredo JC; Stothard JR; Kabatereine NB; Fenwick A; Mutumba-Nakalembe MJ
    Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):400-7. PubMed ID: 22657533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
    Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
    Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serologic and ultrasonographic parameters of praziquantel treatment of hepatic fibrosis in Schistosoma japonicum infection.
    Ohmae H; Tanaka M; Nara T; Utsunomiya H; Taguchi H; Irie Y; Yasuraoka K
    Am J Trop Med Hyg; 1991 Sep; 45(3):350-9. PubMed ID: 1928570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Schistosoma mansoni infection and treatment on drug metabolizing enzymes.
    Ebeid FA; Seif el-Din SH; Ezzat AR
    Arzneimittelforschung; 2000 Sep; 50(9):867-74. PubMed ID: 11050708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of praziquantel treatment on the liver functions, worm burden, and granuloma size using two drug regimen in murine Schistosoma mansoni infection.
    el-Fakahany AF; Abdalla KF; el-Hady HM; Abd el-Aziz SM; Afifi LM
    J Egypt Soc Parasitol; 1993 Dec; 23(3):877-86. PubMed ID: 8308363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artemether as adjuvant therapy to praziquantel in murine Egyptian schistosomiasis mansoni.
    Mahmoud MR; Botros SS
    J Parasitol; 2005 Feb; 91(1):175-8. PubMed ID: 15856895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence and intensity of Schistosoma mansoni infection among residents in two Egyptian villages, at two and twelve months post-treatment with 40 and 60 mg praziquantel per kg body weight at these two villages respectively.
    Abu-Elyazeed RR; Mansour NS; Campbell JR
    J Egypt Soc Parasitol; 1998 Apr; 28(1):9-16. PubMed ID: 9617038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of serum copper and zinc levels in chronic Schistosoma mansoni patients with and without hepatic involvement before and after praziquantel therapy.
    el Hawy AM; Abdel Rahman MM; Rozik S; Fawzy AF; el Gammal HA
    J Egypt Soc Parasitol; 1993 Apr; 23(1):55-62. PubMed ID: 8482883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of praziquantel against Schistosoma mansoni-infections in Botswana.
    Friis H; Byskov J
    Trop Geogr Med; 1989 Jan; 41(1):49-51. PubMed ID: 2503911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice.
    Giboda M; Smith JM
    J Trop Med Hyg; 1994 Apr; 97(2):98-102. PubMed ID: 8170010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure.
    Sabra AN; Botros SS
    J Parasitol; 2008 Apr; 94(2):537-41. PubMed ID: 18564758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profile of portal hypertension in hepatosplenic schistosomiasis.
    el-Hawey AM; Abou-Taleb SA; el-Gammal HA; Abdel-Rahman MM; Sabry AA
    J Egypt Soc Parasitol; 1992 Aug; 22(2):305-9. PubMed ID: 1500767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding low uptake of mass treatment for intestinal schistosomiasis among school children: a qualitative study in Jinja district, Uganda.
    Muhumuza S; Olsen A; Nuwaha F; Katahoire A
    J Biosoc Sci; 2015 Jul; 47(4):505-20. PubMed ID: 24735860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
    Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
    Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of combined chemotherapy and anti-inflammatory drugs on murine schistosomiasis.
    Mahmoud MR; Zoheiry MM; Nosseir MM
    Arzneimittelforschung; 2002; 52(4):294-301. PubMed ID: 12040972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.